Twenty-five genes have been identified in which mutations cause epileptic seizures in mice. The gene for a Na + /H + exchanger has recently been found to underlie the spontaneous mutant slow wave epilepsy. Studies of such mutants should help elucidate the mechanisms that control neuronal excitability.
The mouse is a more tractable species for genetic analysis than humans, and the rate of progress in elucidating the genetic basis of inherited epilepsy syndromes in mice has, in the past three years alone, been astounding. Before 1994, only one gene defect had been linked to cortical epilepsy in mice; since then, 24 further single-gene mutations have been linked to an epileptic phenotype ( Table  1 , the genes are mostly listed by the names of their products). Most of these epilepsy genes -20 out of 25 -have been identified in mice in which a gene had experimentally been deleted, modified or, less commonly, overexpressed. In most instances, the epileptic phenotype came as a complete surprise to the investigators. Indeed, epilepsy is arguably the single most common neurological abnormality recognized in mice with induced mutations.
In addition to these induced mutations found to cause epilepsy, a number of spontaneous mutations have been linked to an epileptic phenotype in mice. In a number of cases, the genes affected by these spontaneous mutations have been identified by positional cloning. One example is slow wave epilepsy (SWE), a recently discovered spontaneous mutant that exhibits both ataxia and epileptic seizures. Cox et al. [2] have recently described the phenotype of this mutant mouse, and the results of positional cloning, which demonstrate that the responsible defect is a null mutation of the ubiquitously expressed Na + /H + exchanger, NHE1. This discovery provides a powerful new tool for elucidating the molecular mechanisms controlling neuronal excitability and selective neuronal degeneration.
The mouse genes implicated in epilepsy [3, 4] encode a diverse variety of proteins (Table 1 ), in line with the great diversity of human epilepsy syndromes. The most common category of mutations disrupt the function of chemical synapses, followed by those that affect the intrinsic excitability of neurons. It is not surprising that either type of mutation is associated with an epileptic phenotype. For example, disruption of synaptic inhibition by targeted deletion of the gene encoding the γ-amino butyric acid type A (GABA A ) receptor would be expected to result in increased neuronal excitability. Genes involved in determining the structural organization of the nervous system have also been linked to epilepsy, consistent with the common occurrence of epilepsy in humans with cortical dysgenesis. For many of the remaining genes listed in Table 1 , including the discovery that the SWE gene encodes a Na + /H + exchanger, the epileptic mutant phenotype undoubtedly came as a surprise to the investigators. But such unexpected results are often of considerably greater interest, and more informative, than the expected ones.
The discovery that the SWE gene encodes the Na + /H + exchanger NHE1 opens a rich array of questions of considerable interest to biologists. NHE1 contributes to regulation of intracellular pH and cell volume, as well as mitogenic responses to growth factors [5] . NHE1 is activated when the cell is acidified, promoting return of the intracellular pH to its steady-state level. This protein is expressed in many organs of the mouse, yet the phenotype is restricted to the brain. Might other Na + /H + exchangers compensate for the absence of NHE1 in other organs, or does NHE1 have only a trivial contribution to cellular homeostasis in other organs? SWE mice exhibit ataxia (impaired motor control), presumably because of the degeneration of deep cerebellar nuclei; neurons in the vestibular and cochlear nuclei also undergo degeneration in these mutants. Who would have thought that a deficiency of NHE1 would cause neurons to degenerate? What is the underlying mechanism? Why does the degeneration target these neurons in particular, and spare those elsewhere in the nervous system? Cox et al. [2] note that the three nuclei undergoing degeneration are among those with the highest basal metabolic rates [6] . As one consequence of a high basal metabolic rate -and presumably a concomitantly high rate of neuronal firing -is a reduced internal pH [7, 8] , Cox et al. [2] suggest that neurons in these nuclei may be particularly dependent upon NHE1 activity.
How does the absence of NHE1 cause seizures? The seizures exhibited by the SWE mutants are similar to absence, or petit mal, seizures in humans, in that they are characterized by a brief behavioral arrest in association with a distinctive electroencephalographic abnormality consisting of 3-4 per second spike-wave discharge. Moreover, the seizures in the SWE mouse and humans with petit mal epilepsy are both suppressed by the anticonvulsant ethosuximide. Absence seizures are caused by the reciprocal synchronized firing of neurons in the thalamus and cerebral cortex [9] , circuitry that likely subserve physiologic functions of cortical synchronization during sleep. Many possible mechanisms could account for the increased excitability of these neurons, as a wide diversity of neuronal signaling mechanisms are exquisitely sensitive to pH, including ligand-and voltage-gated ion channels, intracellular signal transduction pathways and even gap junctions between neurons.
An interesting possibility suggested by Cox et al. [2] is that the mechanism of the increased neuronal excitability in SWE mice is secondary to defective NHE1 activity in the surrounding astrocytes, rather than in the neurons themselves. One consequence of this defect in astrocytes may be reduced H + transport to the extracellular space, and a net alkalinization of the extracellular fluid. This seems to be a plausible mechanism, because hyperventilation -which reduces arterial CO 2 content and produces an alkalosis -reliably triggers absence seizures in children with the petit mal epilepsy disorder [10] .
Apart from these questions of fundamental biological interest, the discovery made by Cox et al. [2] may help elucidate cellular and molecular mechanisms of absence seizures in humans. The striking similarities of the seizures in mouse and man strengthen the likelihood that the defect in the mouse may somehow provide a clue to genetic defects in humans with absence seizures. Perhaps a genetic deficiency of NHE1 itself underlies some forms of absence seizures in humans. Alternatively, perhaps the NHE1 defect will shed light on a signaling cascade that culminates in increased cortical excitability, and affected Dispatch R169 Table 1 Mouse genes linked to an epileptic phenotype. Mutant mice with phenotypes that involve seizures are providing biologists with an abundance of riches. Questions similar to those raised concerning the SWE mutant are also being asked about many of the other mouse mutants in which epilepsy is part of the phenotype. Answers to these questions will teach us valuable lessons about the genetic control of neuronal excitability in physiologic circumstances. One consequence of this line of investigation is also likely to be new ways of preventing, or more effectively controlling, human epilepsies.
